Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence?

Area of Science:

• Immunology
• Pathogenesis
• Fibrotic Diseases

Background:

• The exact cause of systemic sclerosis (SSc) is unknown.
• Immune cells, particularly macrophages and monocytes, are implicated in SSc development.
• Macrophages/monocytes exist in distinct phenotypes: pro-inflammatory M1 and pro-fibrotic/anti-inflammatory M2.

Purpose of the Study:

• To review current research on the role of macrophages and monocytes in systemic sclerosis pathogenesis.
• To elucidate the contribution of different macrophage/monocyte phenotypes to SSc.
• To highlight key findings regarding immune cell involvement in SSc.

Main Methods:

• Literature review of relevant scientific research.
• Analysis of studies focusing on macrophage and monocyte involvement in SSc.
• Synthesis of findings on M1 and M2 phenotypes in SSc pathogenesis.

Main Results:

• Macrophages and monocytes are central to SSc pathogenesis.
• Both M1 and M2 macrophage/monocyte phenotypes appear to contribute to the disease process.
• Evidence suggests these cells initiate and perpetuate SSc.

Conclusions:

• Macrophages and monocytes are critical players in the unknown pathogenesis of systemic sclerosis.
• Understanding the dual role of M1 and M2 phenotypes is crucial for SSc research.
• Further investigation into these immune cells may reveal therapeutic targets for SSc.